Harvard Bioscience makes laboratory instruments and software used in life science research and preclinical drug testing. It last closed at $9.08 on Nov 17, up 1.91% on the day.
HBIO · as of the Nov 17 close · updated after every close
Uptrend
The stock is 4% above its 20 day and 8% above its 50 day average. It is 27% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 56). The nearest support is the Pivot S1 at $8.82, and the nearest resistance the swing high (Nov 2) at $9.10.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityNormal, 5.6%/day
Key levels
$10.2052 week high+12.3%
$9.34Pivot R1+2.9%
$9.10Swing high (Nov 2)+0.2%
$9.08Pivot+0.0%
$9.08Last close
$8.82Pivot S1−2.9%
$8.7620 day average−3.5%
$8.3850 day average−7.7%
$8.11Swing low (Nov 6)−10.7%
$7.52100 day average−17.2%
$6.63200 day average−27.0%
$4.0052 week low−55.9%
Indicators
RSI (14)
56.10
Middle of its range
Neutral
MACD
0.26
Above its signal line
Bullish
Stochastic
50.0
Middle of its range
Neutral
ADX (14)
21.0
Weak trend
Williams %R
-53.6
Oversold below −80, overbought above −20
Neutral
CCI (20)
56.3
Oversold below −100, overbought above 100
Neutral
Rate of change
+4.7%
Change over 10 sessions
Bullish
ATR (14)
$0.51
Typical daily range, 5.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Bounce inside a longer downtrend, nearing overbought
Short trendBullish
Long trendBearish
MomentumStrong
StretchNear overbought
VolatilityLow, 8.9%/day
Key levels
$10.2052 week high+12.3%
$9.34Pivot R1+2.9%
$9.10Swing high (Nov 2)+0.2%
$9.08Pivot+0.0%
$9.08Last close
$8.82Pivot S1−2.9%
$8.7620 day average−3.5%
$8.3850 day average−7.7%
$8.11Swing low (Nov 6)−10.7%
$7.52100 day average−17.2%
$6.63200 day average−27.0%
$4.0052 week low−55.9%
Indicators
RSI (14)
65.09
Strong, overbought above 70
Neutral
MACD
0.73
Above its signal line
Bullish
Stochastic
76.2
Middle of its range
Neutral
ADX (14)
44.1
Strong uptrend
Williams %R
-29.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
111.3
Oversold below −100, overbought above 100
Overbought
Rate of change
+13.1%
Change over 10 sessions
Bullish
ATR (14)
$0.80
Typical daily range, 8.8% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Below
What happened before, for HBIO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how HBIO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow HBIO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How HBIO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HBIO is in one of them and how their past HBIO trades turned out.
Harvard Bioscience makes laboratory instruments, consumables, software and services used in life science research, drug discovery and preclinical testing. Its products include electroporation systems, syringe pumps, spectrophotometers, electrophysiology equipment and telemetry systems that collect data from research animals. Customers include pharmaceutical and biotechnology companies, contract research organizations, universities and government laboratories. The company is based in Holliston, Massachusetts, and sells in the United States, Europe and China.